Program: Franco-Romanian Hematology Workshop 2014
Cluj-Napoca, 2-4 October 2014, Ion Chiricuta Oncology Institute and Iuliu Hatieganu
University of Medicine and Pharmacy
October 2nd, 2014
14:00-15:00
Bristol Myers Squibb Satellite Symposium: Sprycel & European
LeukemiaNet (ELN) recommendations for the management of chronic
myeloid leukaemia. A Vasilache, Cluj
15:15 Lunch. Maestro restaurant
October 3rd, 2014
14:00. Registration opens
14:20. Opening remarks: M Zdrenghea, A Tempescul
14:30. Lymphoma and Leukemia-clinical:
Roche Symposium
14:30. (R)evolution in the treatment of Chronic Lymphocytic Leukemia.
Anca Bojan, Cluj
15:00. MabThera SC: from science to practice. A Vasilache, Cluj
15:30
Coffee Break
15:35. First and second-generation immunotherapy in lymphoma. A Tempescul, Brest
16:00. Lymphoma and Leukemia-clinical:
Bristol Myers Squibb Symposium.
Sprycel: Efficacy and safety in the treatment of patients with chronic myeloid
leukaemia. L Urian, Cluj
17:00. Preclinical hematology/immunology workshop. Chair A Tempescul
17:00 . Candidate SNPs as predictors of treatment non-response to the first anti- TNF-alpha
agent in ankylosing spondylitis. R E Schiotis
17:10 . IL-10 interaction with innate interferons in viral infection. C Bocsan
17:20. Amyotrophic Lateral Sclerosis (ALS) versus Multifocal Motor Neuropathy with
Conduction Blocks (MMN): an immunological comparison on the margin of a clinical case.
Major Zoltán Zsigmond
17:30. Natalizumab and growth factors (BDNF and GDNF) in multiple sclerosis (MS). V
Vitalie
17:30 Coffee Break
17:40. B cell anergy at crossroads between leukemia and autoimmunity. Y
Renaudineau, Brest
18:20. Ciprian Tomuleasa. Title TBA
18:40. Management of a successful research lab. M Edwards, Imperial College
London
19:10. NLRC5 – a novel transcriptional regulator of MHC class I. S Chelbi,
Lausanne
19:35. Closing remarks
20:10
Dinner-Restaurant Lugano
October 4th, 2014
9:30-12:30
Experimantal and Laboratory Hematology Workshop (pre-booking required).
IOCN-Hematologie